Key Takeaways
- Prolonged grief disorder, newly recognized in the DSM-5-TR, is a distinct condition from major depressive disorder, with different symptom profiles, neurobiological underpinnings, and treatment requirements.
- Complicated grief and depression drive addiction through different mechanisms: grief produces yearning-based substance use focused on maintaining connection with the deceased, while depression produces anhedonia-based use focused on relief from emptiness and hopelessness.
- Standard antidepressant treatment, effective for depression, shows limited efficacy for complicated grief, which responds better to targeted grief therapy such as complicated grief treatment (CGT).
- Misdiagnosing complicated grief as depression in addiction treatment leads to inappropriate interventions that fail to address the yearning, separation distress, and identity disruption that drive the individual's substance use.
- Trust SoCal in Orange County provides grief-informed dual diagnosis treatment that accurately distinguishes between grief and depression and delivers targeted interventions for each.
Understanding Prolonged Grief Disorder: A New Diagnostic Entity
The inclusion of prolonged grief disorder in the DSM-5-TR in 2022 represented a significant development in psychiatric nosology, formally recognizing that grief can become a distinct clinical condition requiring specific treatment. Prolonged grief disorder is characterized by persistent, pervasive grief involving yearning for and preoccupation with the deceased person that persists for at least 12 months following the death, accompanied by symptoms such as disbelief about the death, emotional numbness, difficulty engaging with ongoing life, identity disruption, and the sense that life is meaningless without the deceased.
The distinction between prolonged grief disorder and normal bereavement is important. Grief is a natural, adaptive response to loss that involves pain but also facilitates adjustment to life without the deceased. In most cases, the acute intensity of grief gradually diminishes over months as the individual assimilates the reality of the loss and reconstructs a meaningful life narrative. In prolonged grief disorder, this natural integration process is disrupted, and the individual becomes stuck in an acute grief state that does not resolve with the passage of time.
At Trust SoCal in Orange County, the recognition of prolonged grief disorder has transformed how we approach clients who present with both loss-related distress and substance use disorders. Rather than subsuming grief under a depression diagnosis, we assess for and treat grief as the distinct clinical entity that current evidence supports it to be.
The DSM-5-TR estimates that prolonged grief disorder affects approximately 4 to 10 percent of bereaved individuals, with higher rates following sudden, violent, or unexpected deaths, multiple losses, and deaths of children or partners. Individuals with pre-existing substance use disorders are at elevated risk for developing prolonged grief following bereavement.
How Complicated Grief and Depression Differ
Although complicated grief and major depressive disorder share surface-level features such as sadness, sleep disturbance, appetite changes, and functional impairment, they differ fundamentally in their emotional core, cognitive content, and neurobiological substrates. Understanding these differences is essential for accurate diagnosis and effective treatment.
The Emotional Core
The central emotional experience of complicated grief is yearning, an intense, persistent longing for the deceased person that produces separation distress analogous to the panic of attachment disruption. This yearning is focused specifically on the lost relationship and may include intense episodes of grief pangs triggered by reminders of the deceased, waves of sorrow when the absence is acutely felt, and a persistent sense of searching for someone who cannot be found.
The central emotional experience of depression, by contrast, is pervasive low mood and anhedonia, a loss of the capacity to experience pleasure or interest in activities that extends across all domains of life. Depression produces a global depletion of emotional vitality rather than the relationship-focused yearning of grief. A depressed person may feel nothing about anything; a grieving person feels intensely about one specific loss.
- Grief: yearning, separation distress, and wave-like episodes of acute sorrow focused on the deceased
- Depression: pervasive low mood, anhedonia, and global loss of interest and pleasure across all life domains
- Grief: moments of positive emotion when memories of the deceased bring comfort alongside pain
- Depression: persistent inability to experience positive emotion regardless of context or memory
- Grief: self-concept remains relatively intact, identity disruption focused on who one is without the deceased
- Depression: pervasive feelings of worthlessness, guilt, and self-deprecation
Different Neurobiological Substrates
Neuroimaging research has revealed distinct brain activation patterns in complicated grief compared to depression. Complicated grief activates the nucleus accumbens, a reward center associated with attachment and craving, suggesting that yearning for the deceased engages the same neural circuitry as craving a substance or desiring reunion with an attachment figure. Depression, by contrast, is characterized by reduced activity in reward circuits and altered function of prefrontal regulatory regions.
This neurobiological distinction has profound implications for addiction. Complicated grief activates craving circuits; depression deactivates reward circuits. Both can drive substance use, but through different neural mechanisms that respond to different interventions. Understanding which mechanism is primary guides treatment selection and improves outcomes.
Different Pathways From Grief and Depression to Addiction
The distinctive emotional and neurobiological profiles of complicated grief and depression produce different pathways to substance use that require different treatment approaches.
Complicated grief drives substance use primarily through the management of yearning and separation distress. Alcohol may be used to numb the waves of acute sorrow that wash over the individual when grief is triggered. Opioids are particularly associated with grief-related substance use because they target the same endogenous opioid system that modulates attachment bonding and separation distress. The opioid warmth pharmacologically mimics the sense of connection that the bereaved person desperately seeks. Some individuals use substances in ritualized patterns connected to the deceased, drinking the deceased's favorite drink, using at sites associated with shared experiences, or using substances as part of mourning rituals that maintain a sense of connection.
Depression drives substance use primarily through the management of emptiness, hopelessness, and anhedonia. When the capacity to experience pleasure is neurobiologically depleted, substances provide pharmacological stimulation of reward circuits that the depressed brain cannot activate naturally. Stimulants may counteract the psychomotor retardation and fatigue of depression. Alcohol may provide brief escape from the relentless gray of depressive emptiness. The substance use in depression is less about managing a specific loss and more about surviving a global depletion of emotional vitality.
Grief-related overdose risk is particularly elevated in the first year following a significant loss, especially when opioids are involved. The combination of grief-driven substance use escalation, reduced concern for personal safety, and passive or active suicidal ideation creates a dangerous convergence. If you are grieving and using substances, please reach out to Trust SoCal at (949) 280-8360.
Why Treatment Must Distinguish Between Grief and Depression
The most clinically significant reason for distinguishing between complicated grief and depression in addiction treatment is that they respond to different interventions. Treating one as if it were the other produces suboptimal outcomes that can prolong suffering and increase relapse risk.
SSRIs and other antidepressants, the pharmacological backbone of depression treatment, show limited efficacy for the core yearning and separation distress of complicated grief. While they may help with sleep, anxiety, and depressive symptoms that co-occur with grief, they do not resolve the grief itself. Individuals who are prescribed antidepressants for what is actually complicated grief may conclude that medication does not work for them, when in reality they have received the wrong treatment for their condition.
Conversely, complicated grief treatment, the evidence-based psychotherapy developed by M. Katherine Shear, specifically targets the disrupted grief processing that maintains prolonged grief disorder. CGT includes elements of motivational interviewing, exposure to grief cues, cognitive restructuring of maladaptive grief-related thoughts, and guided reconstruction of a meaningful life narrative. These elements address the specific mechanisms of complicated grief in ways that standard depression-focused CBT or interpersonal therapy do not.
Integrated Treatment Approach at Trust SoCal
Trust SoCal's dual diagnosis programming includes specific assessment for prolonged grief disorder using validated screening instruments such as the Prolonged Grief-13 and the Inventory of Complicated Grief. When complicated grief is identified, treatment incorporates grief-specific interventions alongside addiction treatment rather than subsumming grief under a depression diagnosis.
- Dedicated assessment for prolonged grief disorder separate from depression screening
- Complicated grief treatment elements integrated into individual therapy, including graduated exposure to grief triggers and loss-related narrative work
- Grief-specific group therapy that addresses bereavement-related substance use patterns distinct from general depression or anxiety-driven use
- Careful pharmacological management that recognizes the limitations of antidepressants for grief and incorporates appropriate adjunctive medications
- Aftercare planning that includes ongoing grief therapy and connection with bereavement support resources
Loss in the Context of Addiction: Multiple Griefs
Individuals entering addiction treatment are frequently carrying multiple unprocessed losses that may include grief from death, as well as the many non-death losses that addiction produces. The loss of relationships, careers, health, self-respect, custody of children, financial security, and years consumed by active addiction all constitute real losses that require grief processing. These addiction-related losses may layer upon bereavement to create a cumulative grief burden that is overwhelming.
Furthermore, the loss of the substance itself during treatment can activate a grief response, particularly for individuals whose relationship with the substance functioned as an attachment bond. Acknowledging this grief, rather than dismissing it as inappropriately mourning a harmful substance, allows it to be processed therapeutically rather than driving covert resentment and eventual relapse.
Trust SoCal creates therapeutic space for processing all forms of loss within addiction treatment, recognizing that unprocessed grief of any kind, whether from death, relationship dissolution, or the accumulated losses of active addiction, can undermine recovery if it is not acknowledged and addressed.
In addiction recovery, grief can emerge unexpectedly as the numbing effects of substances wear off and emotions that were suppressed during active use become accessible. This emergence of grief in early sobriety is a normal and important part of the recovery process, not a sign that treatment is failing. Clinicians should anticipate and create space for this emotional emergence.
Moving Forward: Carrying Grief Without Being Carried by Substances
The goal of grief-informed addiction treatment is not the elimination of grief, which would be neither possible nor desirable, but the development of the capacity to carry grief without being destroyed by it and without requiring substances to survive it. Grief for a significant loss is a permanent feature of the emotional landscape, and recovery involves learning to live with that grief rather than attempting to escape it through chemical means.
Complicated grief treatment facilitates the transition from acute, disabling grief to integrated, bearable grief through a process that includes accepting the reality of the loss, differentiating painful grief from restorative grief, finding ways to maintain a continuing bond with the deceased that does not prevent engagement with ongoing life, and gradually reconstructing a life narrative that incorporates the loss as a central but not solely defining chapter.
Trust SoCal in Orange County provides the clinical expertise necessary to guide individuals through this delicate process while simultaneously supporting their recovery from substance use disorders. Our grief-informed dual diagnosis approach ensures that the pain of loss is honored and processed rather than suppressed or bypassed, creating a foundation for recovery that is honest, sustainable, and respectful of the individual's full emotional experience. Call (949) 280-8360 to discuss confidential treatment options.
Medical Review Board, MD, ABAM
Medical Director & Reviewer
